Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018


Cppgroup Share Chat (CPP)



Share Price: 13.375Bid: 13.25Ask: 13.50Change: 0.00 (0.00%)No Movement on Cppgroup
Spread: 0.25Spread as %: 1.89%Open: 13.50High: 13.50Low: 13.50Yesterday’s Close: 13.375


Share Discussion for Cppgroup


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


legobrickgirl
Posts: 4,478
Off Topic
Opinion:No Opinion
Price:14.00
cpp
6 Nov '17
Another share I have dipped into recently. Looks to be in a great position to move forward.

gla
 
tomj2811
Posts: 7
Off Topic
Opinion:No Opinion
Price:13.125
RE: 3 Million buy
4 Nov '17
They have a new website as well https://uk.cppgroup.com
slipperyslope
Posts: 4,041
Off Topic
Opinion:No Opinion
Price:12.75
RE: 3 Million buy
2 Nov '17
I see that Sir Richard has been increasing his holding by a large amount over this year. Hopefully some more good news on the way in terms of increased revenue.
Morley
Posts: 418
Off Topic
Opinion:No Opinion
Price:12.75
Phoenix reduce hold 39.1% to 38.8%
2 Nov '17
Guess the 3 million came from them direct which is why there is no climb in buy price.
slipperyslope
Posts: 4,041
Off Topic
Opinion:No Opinion
Price:12.25
RE: 3 Million buy
2 Nov '17
RNS out showing that was another director buy yesterday for Sir Richard Lapthorne. Last year the sp at this time was around the 5/6p mark and shot up to 16p in November with that trading statement coming out on the 18th. Looks like a good time to be buying again and should see a nice xmas present here.
slipperyslope
Posts: 4,041
Off Topic
Opinion:No Opinion
Price:12.25
3 Million buy
2 Nov '17
3 Million buy plus some other large transactions gone through yesterday. We had that nice trading statement on 18th November 2016. Perhaps another materially ahead of expectations statement coming out again this month.
Morley
Posts: 418
Off Topic
Opinion:No Opinion
Price:12.375
So blink is a rebrand also ?
30 Oct '17
Through Blink, CPP will extend its regulatory presence in the UK ""and an application for full trading permissions is in the process of being submitted to the FCA"". The Group will use Blink as a platform to develop innovative assistance and insurance products both for the UK market and internationally. """In the UK this will also involve a relaunch of the UK's distribution network""".
Morley
Posts: 418
Off Topic
Opinion:No Opinion
Price:12.50
RE: Same Director bought another 25..
27 Oct '17
Shows that an insider has confidence in the company as these are not share awards but straight purchases.

Hundred grand of his personnel money invested.

Keeps me feeling relaxed about the long term prospects here tbh.

Still a bit boring though.
slipperyslope
Posts: 4,041
Off Topic
Opinion:No Opinion
Price:12.50
RE: Same Director bought another 25..
27 Oct '17
Hi Morley. Added some more myself as well while sp been down. Hanging on to these now until back to that £1 at very least. Could start to get interesting from here.
Morley
Posts: 418
Off Topic
Opinion:No Opinion
Price:12.25
Same Director bought another 250K
27 Oct '17
Same Director bought another 250K




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.